BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20541383)

  • 41. Factors that delay COPD detection in the general elderly population.
    Horie J; Murata S; Hayashi S; Murata J; Miyazaki J; Mizota K; Horikawa E
    Respir Care; 2011 Aug; 56(8):1143-50. PubMed ID: 21496370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease.
    Doehner W; Haeusler KG; Endres M; Anker SD; MacNee W; Lainscak M
    Respir Med; 2011 Oct; 105 Suppl 1():S12-9. PubMed ID: 22015080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Respiratory and Limb Muscle Dysfunction in COPD.
    Barreiro E; Gea J
    COPD; 2015 Aug; 12(4):413-26. PubMed ID: 25438125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of MicroRNAs in COPD muscle dysfunction and mass loss: implications on the clinic.
    Barreiro E
    Expert Rev Respir Med; 2016 Sep; 10(9):1011-22. PubMed ID: 27348064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [COPD: not just the airway matters].
    Rodríguez González-Moro JM; de Lucas Ramos P
    Med Clin (Barc); 2004 Apr; 122(14):535-6. PubMed ID: 15117646
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical consequences of muscle dysfunction in chronic obstructive pulmonary disease].
    Sauleda Roig J
    Nutr Hosp; 2006 May; 21 Suppl 3():69-75. PubMed ID: 16768033
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients.
    Jaitovich A; Barreiro E
    Am J Respir Crit Care Med; 2018 Jul; 198(2):175-186. PubMed ID: 29554438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Skeletal muscles in chronic airflow obstruction: why bother?
    Maltais F
    Am J Respir Crit Care Med; 2003 Oct; 168(8):916-7. PubMed ID: 14555457
    [No Abstract]   [Full Text] [Related]  

  • 49. Neuromuscular weakness in chronic obstructive pulmonary disease: chest wall, diaphragm, and peripheral muscle contributions.
    Alter A; Aboussouan LS; Mireles-Cabodevila E
    Curr Opin Pulm Med; 2017 Mar; 23(2):129-138. PubMed ID: 28079615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utilisation of spirometry among hospitalised patients with clinical findings of COPD in a tertiary hospital in Nigeria.
    Desalu OO; Salami AK; Fawibe AE; Oluboyo PO
    Niger Postgrad Med J; 2011 Mar; 18(1):26-9. PubMed ID: 21445105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COPD exacerbations -- a comparison of Irish data with European data from the ERS COPD Audit.
    Crinion S; Cotter O; Kennedy B; O'Connor B; Curran DR; McCormack S; McDonnell TJ; O'Connor TM
    Ir Med J; 2013 Oct; 106(9):268, 270-2. PubMed ID: 24416848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.
    Spruit MA; Gosselink R; Troosters T; Kasran A; Gayan-Ramirez G; Bogaerts P; Bouillon R; Decramer M
    Thorax; 2003 Sep; 58(9):752-6. PubMed ID: 12947130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors associated with the rate of COPD exacerbations that require hospitalization.
    Pavlovic R; Stefanovic S; Lazic Z; Jankovic S
    Turk J Med Sci; 2017 Feb; 47(1):134-141. PubMed ID: 28263481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exercise capacity in chronic respiratory diseases.
    Fiorenzano G; Santoriello C; Musella V; Polverino M
    Eur Respir J; 2010 May; 35(5):1193-4. PubMed ID: 20436181
    [No Abstract]   [Full Text] [Related]  

  • 55. [Physiologic particularities of muscle impairments in the patient with COPD].
    Gea J; Orozco-Levi M; Barreiro E
    Nutr Hosp; 2006 May; 21 Suppl 3():62-8. PubMed ID: 16768032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Muscle dysfunction in COPD.
    Barreiro E; Sieck G
    J Appl Physiol (1985); 2013 May; 114(9):1220-1. PubMed ID: 23393064
    [No Abstract]   [Full Text] [Related]  

  • 57. Handgrip weakness and mortality risk in COPD: a multicentre analysis.
    Burtin C; Ter Riet G; Puhan MA; Waschki B; Garcia-Aymerich J; Pinto-Plata V; Celli B; Watz H; Spruit MA
    Thorax; 2016 Jan; 71(1):86-7. PubMed ID: 26514408
    [No Abstract]   [Full Text] [Related]  

  • 58. Aspects of skeletal muscles in chronic respiratory disease.
    Man WD
    Chron Respir Dis; 2016 Aug; 13(3):295-6. PubMed ID: 27488127
    [No Abstract]   [Full Text] [Related]  

  • 59. Pulmonary features associated with being underweight in older men.
    Yamaguchi Y; Hibi S; Ishii M; Hanaoka Y; Kage H; Yamamoto H; Yamauchi Y; Eto M; Nagase T; Ouchi Y
    J Am Geriatr Soc; 2011 Aug; 59(8):1558-60. PubMed ID: 21848827
    [No Abstract]   [Full Text] [Related]  

  • 60. Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD.
    Beghé B; Verduri A; Roca M; Fabbri LM
    Eur Respir J; 2013 Apr; 41(4):993-5. PubMed ID: 23543648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.